Impact of baseline blood pressure on all-cause mortality in patients with atrial fibrillation: results from a multicenter registry study

被引:3
|
作者
Xu, Wei [1 ]
Song, Qirui [2 ]
Zhang, Han [1 ]
Wang, Juan [1 ]
Shao, Xinghui [1 ]
Wu, Shuang [1 ]
Zhu, Jun [1 ]
Cai, Jun [2 ]
Yang, Yanmin [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Emergency Ctr, State Key Lab Cardiovasc Dis China,Nat Ctr Cardiov, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Hypertens Ctr, Natl Ctr Cardiovasc Dis China, Fuwai Hosp,State Key Lab Cardiovasc Dis China,Nat, Beijing 100037, Peoples R China
关键词
All-cause death; All-cause mortality; Atrial fibrillation; Blood pressure; Diastolic blood pressure; Hypertension; Systolic blood pressure; CLINICAL-OUTCOMES; RISK; HYPERTENSION; ASSOCIATION; AFFIRM;
D O I
10.1097/CM9.0000000000002627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:The ideal blood pressure (BP) target for patients with atrial fibrillation (AF) is still unclear. The present study aimed to assess the effect of the baseline BP on all-cause mortality in patients with AF.Methods:This registry study included 20 emergency centers across China and consecutively enrolled patients with AF from 2008 to 2011. All participants were followed for 1 year +/- 1 month. The primary endpoint was all-cause mortality.Results:During the follow-up, 276 (13.9%) all-cause deaths occurred. Kaplan-Meier curves showed that a systolic blood pressure (SBP) <= 110 mmHg or >160 mmHg was associated with a higher risk of all-cause mortality (log-rank test, P = 0.014), and a diastolic blood pressure (DBP) <70 mmHg was associated with the highest risk of all-cause mortality (log-rank test, P = 0.002). After adjusting for confounders, the multivariable Cox regression model suggested that the risk of all-cause mortality was increased in the group with SBP <= 110 mmHg (hazard ratio [HR], 1.963; 95% confidence interval [CI], 1.306-2.951), and DBP <70 mmHg (HR, 1.628; 95% CI, 1.163-2.281). In the restricted cubic splines, relations between baseline SBP or DBP and all-cause mortality showed J-shaped associations (non-linear P P = 0.010, respectively). The risk of all-cause mortality notably increased at a lower baseline SBP and DBP.Conclusions:Having a baseline SBP <= 110 mmHg or DBP <70 mmHg was associated with a significantly higher risk of all-cause mortality in patients with AF. An excessively low BP may not be an optimal target for patients with AF.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 50 条
  • [31] Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
    Rao, Shishir
    Nazarzadeh, Milad
    Canoy, Dexter
    Li, Yikuan
    Huang, Jing
    Mamouei, Mohammad
    Salimi-Khorshidi, Gholamreza
    Schutte, Aletta E.
    Neal, Bruce
    Smith, George Davey
    Rahimi, Kazem
    EUROPEAN HEART JOURNAL, 2023, 44 (42) : 4448 - 4457
  • [32] The Relationship of All-Cause Mortality to Average On-Treatment Systolic Blood Pressure is Significantly Related to Baseline Systolic Blood Pressure: Implications for Interpretation of the SPRINT Study
    Okin, Peter M.
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    CIRCULATION, 2016, 134
  • [33] The impact of visit-to-visit heart rate variability on all-cause mortality in atrial fibrillation
    Zhou, Xiaoyan
    Yuan, Qinghua
    Yuan, Jie
    Du, Zhi-Min
    Zhuang, Xiaodong
    Liao, Xinxue
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2024, 29 (01)
  • [34] Comparison of intradialytic blood pressure metrics as predictors of all-cause mortality
    Kim, Ka Young
    Park, Hae Sang
    Kim, Jin Sun
    Ahn, Shin Young
    Ko, Gang Jee
    Kwon, Young Joo
    Kim, Ji Eun
    CLINICAL KIDNEY JOURNAL, 2021, 14 (12) : 2600 - 2605
  • [35] Combined effect of visit-to-visit variations in heart rate and systolic blood pressure on all-cause mortality in hypertensive patients
    Zhao, MaoXiang
    Yao, Siyu
    Li, Yao
    Wang, Miao
    Wang, Chi
    Yun, Cuijuan
    Zhang, Sijin
    Sun, Yizhen
    Hou, Ziwei
    Wu, Shouling
    Xue, Hao
    HYPERTENSION RESEARCH, 2021, 44 (10) : 1291 - 1299
  • [36] Patterns of Anticoagulation Use and All-Cause of Mortality in Cancer Patients with Atrial Fibrillation
    Han, Xu
    Yang, Xiaolei
    Hidru, Tesfaldet H.
    Wang, Chengfang
    Xia, Yunlong
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (02) : 244 - 253
  • [37] Blood Pressure Control in Community Dwelling Patients with Atrial Fibrillation: Results from the ORBIT-AF Registry
    Vemulapalli, Sreekanth
    Kim, Sunghee
    Thomas, Laine
    Piccini, Jonathan P.
    Patel, Manesh R.
    Chang, Paul
    Fonarow, Gregg C.
    Ezekowitz, Michael D.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Gersh, Bernard J.
    Peterson, Eric D.
    CIRCULATION, 2014, 130
  • [38] Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
    Dong, Zhaojie
    Du, Xin
    Lu, Shangxin
    Jiang, Chao
    Xia, Shijun
    He, Liu
    Su, Xin
    Jia, Zhaoxu
    Long, Deyong
    Sang, Caihua
    Tang, Ribo
    Liu, Nian
    Bai, Rong
    Yu, Ronghui
    Dong, Jianzeng
    Ma, Changsheng
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [39] Exercise-Based Cardiac Rehabilitation and All-Cause Mortality Among Patients With Atrial Fibrillation
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lane, Deirdre A.
    Thijssen, Dick H. J.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (12):
  • [40] Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications Results From the POINTED Registry
    Palmisano, Pietro
    Guerra, Federico
    Dell'Erra, Gabriele
    Ammendola, Ernesto
    Ziacchi, Matteo
    Laffi, Mattia
    Troiano, Francesca
    Prenna, Eleonora
    Russo, Vincenzo
    Angeletti, Andrea
    Guido, Alessandro
    Occhetta, Eraldo
    Nigro, Gerardo
    Biffi, Mauro
    Gaggioli, Germano
    Capucci, Alessandro
    Accogli, Michele
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (04) : 382 - 392